ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 41 filers reported holding ENOCHIAN BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,810 | -63.0% | 29,648 | -40.3% | 0.00% | – |
| Q1 2023 | $45,433 | -5.1% | 49,654 | +6.9% | 0.00% | – |
| Q4 2022 | $47,861 | -43.0% | 46,467 | +0.3% | 0.00% | – |
| Q3 2022 | $84,000 | +366.7% | 46,334 | +395.9% | 0.00% | – |
| Q2 2022 | $18,000 | -41.9% | 9,343 | +6.4% | 0.00% | – |
| Q1 2021 | $31,000 | +10.7% | 8,782 | -8.8% | 0.00% | – |
| Q4 2020 | $28,000 | +12.0% | 9,625 | +40.5% | 0.00% | – |
| Q3 2020 | $25,000 | -3.8% | 6,852 | +10.9% | 0.00% | – |
| Q2 2020 | $26,000 | +100.0% | 6,178 | +42.4% | 0.00% | – |
| Q1 2020 | $13,000 | -51.9% | 4,338 | -20.8% | 0.00% | – |
| Q4 2019 | $27,000 | +440.0% | 5,476 | +418.1% | 0.00% | – |
| Q3 2019 | $5,000 | -58.3% | 1,057 | -65.0% | 0.00% | – |
| Q2 2019 | $12,000 | -90.6% | 3,022 | -83.6% | 0.00% | – |
| Q1 2019 | $127,000 | – | 18,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |